TGFB1 and steatosis: Pathophysiological shifts in steatosis and MASH have been linked to an up-regulation of specific signaling molecules, notably TGF-β and a subset of matrix metalloproteinases, which are thought to play roles in neoplastic pathways and the promotion of angiogenesis [25,26,27,28].